Switching from intravenous to subcutaneous infliximab in patients with immune mediated diseases in clinical remission
在免疫介导疾病临床缓解期患者中，从静脉注射英夫利昔单抗转换为皮下注射英夫利昔单抗
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1583401
Viazis, Nikos; Karamanakos, Anastasios; Mousourakis, Konstantinos; Christidou, Angeliki; Fousekis, Fotios; Mpakogiannis, Konstantinos; Koukoudis, Anastasios; Katsanos, Konstantinos; Christodoulou, Dimitrios; Cheila, Myrto; Tzouvala, Maria; Zacharopoulou, Eirini; Palatianou, Maria; Giouleme, Olga; Katsoula, Anastasia; Liatsos, Christos; Kyriakos, Nikolaos; Zampeli, Evi; Papathanasiou, Evgenia; Theodoropoulou, Angeliki; Karmiris, Konstantinos; Psaroudakis, Ioannis; Tribonias, George; Gazi, Souzanna; Mole, Evangelia; Dimitroulas, Theodoros; Koutsianas, Christos; Vassilopoulos, Dimitris; Fragoulis, George E; Michalakeas, Nikos; Papagoras, Charalampos; Panagakis, Pantelis; Papoutsaki, Marina; Chasapi, Vasiliki; Stratigos, Alexandros; Katsikas, George
